( 09926.hk) | -111.11 | 14.43 | 0% | 上市时间2020-04-24股价110.40港币涨跌幅0.09%成交金额5.78亿港币换手率0.57%市值1,016.94亿港币H股市值1,016.94亿港币总股本9.21亿H股本9.21亿每手股数1,000上市至今年化投资收益率29.70%港股通持仓占H股比例45.66% (474.80亿港币2026-01-28) 累计做空占H股比例6.40% (68.67亿港币2026-01-23) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 66.68 | 市净率 | 5.06 | 股息率 | 0.31% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 |
| ||||||
| 备注 (11): | 双击编辑备注 |
康方生物(09926) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 謝榕剛 | Non Executive Director | 2020-08-19 | -- | |
| 2 | 譚擘 | Independent Non Executive Director - A/F | 2020-04-24 | -- | |
| 3 | 徐岩 | Independent Non Executive Director | 2020-04-24 | -- | |
| 4 | 曾駿文 | Independent Non Executive Director | 2020-04-24 | -- | |
| 5 | 林利軍 | Non Executive Director | 2019-11-16 | 2020-08-19 | |
| 6 | 夏羽 | Executive Director | 2018-11-01 | -- | |
| 7 | 周伊 | Non Executive Director | 2015-07-01 | -- | |
| 8 | 夏瑜 | Executive Director | Chairman, CEO | 2012-03-19 | -- |
| 9 | 李百勇 | Executive Director | 2012-03-01 | -- | |
| 10 | 王忠民 | Executive Director | 2012-03-01 | -- |